Reimagining Hydroxyapatite: Silver Doping for Antibacterial Precision
DOI:
https://doi.org/10.65795/gjtknw73Keywords:
silver, nanoparticles, hydroxyapatite, antibacterialAbstract
Silver-doped hydroxyapatite (Ag-HA) has emerged as a promising biomaterial for antibacterial applications and bone regeneration. The incorporation of silver ions (Ag⁺) into the hydroxyapatite (HA) lattice enhances its antimicrobial properties while maintaining biocompatibility. This study aims to synthesize and characterize Ag-HA composites using the ion exchange method and evaluate their structural, morphological, and antibacterial properties. Ag-HA was synthesized by replacing calcium ions in HA with silver ions through an ion exchange process. A reaction mixture of 0.5 M calcium nitrate and 0.3 M diammonium phosphate was maintained at pH 10 with ammonia, followed by the addition of silver nitrate. The mixture was stirred at room temperature for 24 hours. Characterization was conducted using Fourier-transform infrared spectroscopy (FTIR), X-ray diffraction (XRD), and scanning electron microscopy (SEM) to determine the chemical structure, crystallinity, and morphology. Antibacterial activity was assessed using inhibition zone assays against Escherichia coli and Staphylococcus aureus, while hemolysis studies evaluated biocompatibility. XRD analysis confirmed the hexagonal crystalline structure of HA, with characteristic peaks at 2θ = 25.9°, 31.8°, 32.9°, and 34.1°. SEM images revealed a highly porous, clustered morphology at a 1 µm scale, characteristic of nanoparticle-based materials. Ag-HA demonstrated enhanced antibacterial activity, with inhibition zone diameters of 2.9 cm for E. coli and 1.2 cm for S. aureus, surpassing pure HA. Hemolysis tests showed 2.25% hemolysis, indicating good biocompatibility below the 5% threshold. The synthesized Ag-HA composite exhibited enhanced antibacterial activity and a porous morphology suitable for bone regeneration. With its low hemolysis rate, Ag-HA holds great potential as a biocompatible and antimicrobial biomaterial for biomedical applications.
Downloads
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Kathryn Kiruba, Suganya Panneer Selvam, Radha Gosala, Ramya Ramadoss, Sandhya Sundar (Author)

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright and Licensing
All articles published in Trends in Biomaterials and Artificial Organs are published Open Access. To ensure the widest possible dissemination of research while protecting the integrity of the original work, we utilize the Creative Commons Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) 4.0 International License.
User Rights
Under this license, the public is free to share (copy and redistribute the material in any medium or format) under the following terms:
- Attribution: Users must give appropriate credit, provide a link to the license, and indicate if changes were made.
- Non-Commercial: Users may not use the material for commercial purposes. This includes, but is not limited to, the sale of the article or its use in promotional materials for-profit.
- No Derivatives: If a user remixes, transforms, or builds upon the material, they may not distribute the modified material.
Author Rights
Authors retain copyright of their work while granting the journal a non-exclusive license to publish. Because of the NoDerivs (ND) and Non-Commercial (NC) designations:
- Third parties (such as other researchers) must seek permission from the authors/journal to include figures, tables, or portions of the text in new works or commercial publications.
- Authors may deposit the "Version of Record" in institutional repositories immediately upon publication, provided the CC BY-NC-ND 4.0 license is clearly linked.
How to Cite
Accepted 11-02-2026
Published 24-02-2026


